Mercury Pharmaceuticals

25

Aug 2026

Researchers traced lifelong obesity resistance in mice back to an early microbial encounter

Natural wild-derived microbiota protected mice against diet-induced obesity across sexes, genetic backgrounds, and age by increasing energy expenditure and promoting a thermogenic program in brown adipose tissue. The effect depended on the immune system’s initial encounter with the microbiota and required CCR2-associated myeloid activity, revealing a long-lasting microbiota-immune-brown fat pathway.

READ MORE

25

Aug 2026

Ancient proteins revived to inspire new antimicrobial treatments

University of Oregon biologists have resurrected prehistoric proteins up to 160 million years old that carry natural antimicrobial properties.

READ MORE

25

Aug 2026

Emergency diagnoses of medical conditions predict worse patient survival

Patients diagnosed with conditions after an emergency hospital admission or an emergency room visit face a higher risk of death than those diagnosed in non-emergency settings, according to a large population-based study by Emma Whitfield and colleagues from University College London, UK, published August 25th in the open access journal PLOS Medicine.

READ MORE

25

Aug 2026

Diabetes study reveals differing health risks for men and women

In the years following type 2 diabetes diagnosis, women are more likely to develop mental health conditions, while men are more likely to develop cardiovascular and renal complications, according to a study published August 25th in the open access journal PLOS Medicine by Fabiola Eto from Queen Mary University of London, UK, and colleagues.

READ MORE

25

Aug 2026

Anti-immigrant policies linked to rising HIV cases among Hispanic populations

Following the Trump administration's 2018 announcement of changes to the public charge rule that would penalize immigrants for using public benefit programs, antisanctuary counties in the US saw a 16.8-percent increase in HIV cases among Hispanic populations, compared to baseline counties.

READ MORE

25

Aug 2026

Scientists discover how neutrophils travel to infection sites without damaging healthy tissue

UMass Chan Medical School scientist Beth McCormick, PhD, and her team collaborated with researchers at the University of Bath to discover how neutrophils, the body's most abundant type of white blood cells, travel to infection sites without damaging healthy tissue.

READ MORE

25

Aug 2026

NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers

Researchers at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center have received two grants from the National Institutes of Health (NIH) totaling $7.5 million to study whether exposure to per- and polyfluoroalkyl substances (PFAS), the synthetic compounds known as "forever chemicals," increases the risk of liver cancer and endometrial cancer.

READ MORE

25

Aug 2026

SBRT improves bowel health related quality-of-life in patients with localized intermediate-risk prostate cancer

Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate risk prostate cancer indicate that the use of SBRT improved bowel health related quality of life (HRQOL) in this patient population.

READ MORE

25

Aug 2026

Gene removal makes engineered immune cells more effective against osteosarcoma

Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma.

READ MORE

25

Aug 2026

Standard memory tests fail to detect post-chemotherapy brain fog

Standard memory tests such as word-pair or list-learning tests used in clinics may fail to detect the real-life memory problems reported by many female breast cancer survivors after chemotherapy.

READ MORE